BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18295617)

  • 1. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report.
    Stubblefield MD; Levine A; Custodio CM; Fitzpatrick T
    Arch Phys Med Rehabil; 2008 Mar; 89(3):417-21. PubMed ID: 18295617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
    Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
    Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
    Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
    Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; HordyƄska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
    Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of resistance to botulinum toxin type A in patients with torticollis.
    Greene P; Fahn S; Diamond B
    Mov Disord; 1994 Mar; 9(2):213-7. PubMed ID: 8196686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH; Whyte J; Wannstedt G; Ellis CA
    Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated botulinum toxin injections can improve mobility in patients with spinal cord lesions.
    Catz A; Barkol H; Steinberg F; Ronen J; Bluvshtein V; Keren O
    Eura Medicophys; 2007 Sep; 43(3):319-25. PubMed ID: 17525702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy.
    Rivard PF; Nugent AC; Symons FJ
    Clin J Pain; 2009 Jun; 25(5):413-7. PubMed ID: 19454875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
    Sobolewski P
    Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
    Chen JJ; Wu YN; Huang SC; Lee HM; Wang YL
    Arch Phys Med Rehabil; 2005 Aug; 86(8):1655-60. PubMed ID: 16084822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
    Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
    Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
    Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O
    Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injection into Riolan's muscle: somatosensory 'trick'.
    Inoue K; Rogers JD
    Eur Neurol; 2007; 58(3):138-41. PubMed ID: 17622718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.